Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04528836 |
Title | First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Navire Pharma Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope | Recruiting | Duarte | California | 91010 | United States | Details |
UC Irvine Health | Active, not recruiting | Orange | California | 92868 | United States | Details |
UCLA Hematology/Oncology - Santa Monica | Recruiting | Santa Monica | California | 90404 | United States | Details |
Sarah Cannon Research Institute | Recruiting | Denver | Colorado | 80218 | United States | Details |
The University of Texas MD Anderson Cancer Center | Recruiting | Houston | Texas | 77096 | United States | Details |
NEXT Oncology | Recruiting | San Antonio | Texas | 78229 | United States | Details |
Huntsman Cancer Institute | Recruiting | Salt Lake City | Utah | 84112 | United States | Details |